Back
Caribou Biosciences Vs. Beam Therapeutics Industry Stock Comparison
Buy
52
CRBU
Caribou Biosciences
Last Price:
2.08
Seasonality Move:
-20.16%
Sell
32
BEAM
Beam Therapeutics
Last Price:
26.02
Seasonality Move:
33.43%
Buy
52
Caribou Biosciences (CRBU)
is a Buy
Is Caribou Biosciences a Buy, Sell or Hold?
- The current Caribou Biosciences [CRBU] share price is $2.08. The Score for CRBU is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
- CRBU is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
32
Beam Therapeutics (BEAM)
is a Sell
Is Beam Therapeutics a Buy, Sell or Hold?
- The current Beam Therapeutics [BEAM] share price is $25.51. The Score for BEAM is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
- BEAM is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CRBU Stock Price Chart
What is Caribou Biosciences's stock price today?
-
The Caribou Biosciences share price today is $2.08
The current trend is relatively stagnant and CRBU is experiencing selling pressure, which indicates risk of future bearish movement.
BEAM Stock Price Chart
What is Beam Therapeutics's stock price today?
-
The Beam Therapeutics share price today is $25.51
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BEAM is experiencing slight selling pressure.
CRBU Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.01 | Sell |
Relative Strength Index (14 RSI): | 51.91 | Buy |
Chaikin Money Flow: | -919434 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.92 - 2.18) | Buy |
Bollinger Bands (100): | (1.69 - 3.03) | Sell |
BEAM Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.17 | Sell |
Relative Strength Index (14 RSI): | 51.31 | Buy |
Chaikin Money Flow: | -369164 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (23.91 - 26.21) | Buy |
Bollinger Bands (100): | (22.63 - 27.29) | Buy |
CRBU Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.02 | Buy |
20-day SMA: | 2.04 | Buy |
50-day SMA: | 2.11 | Sell |
200-day SMA: | 4.06 | Sell |
8-day EMA: | 2.04 | Buy |
20-day EMA: | 2.03 | Buy |
50-day EMA: | 2.13 | Sell |
200-day EMA: | 3.5 | Sell |
BEAM Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 24.83 | Buy |
20-day SMA: | 25.22 | Buy |
50-day SMA: | 26.27 | Sell |
200-day SMA: | 27.35 | Sell |
8-day EMA: | 25.17 | Buy |
20-day EMA: | 25.17 | Buy |
50-day EMA: | 25.51 | Buy |
200-day EMA: | 26.94 | Sell |
Caribou Biosciences Earnings Growth & CRBU Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.10 per share, a decrease next quarter of $0.08 per share, a decrease this year of $0.53 per share, and a decrease next year of $0.12 per share.
Beam Therapeutics Earnings Growth & BEAM Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.10 per share, an increase next quarter of $0.03 per share, a decrease this year of $0.46 per share, and an increase next year of $0.07 per share.
Caribou Biosciences Technical Analysis
Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Beam Therapeutics Technical Analysis
Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |